Immunotherapy is a groundbreaking treatment modality that leverages the immune system to combat various diseases, primarily cancer. As advancements in this field continue to evolve, it is crucial for physicians to comprehend its principles and applications.
Immunotherapy, also known as biological therapy, involves the use of living organisms, substances derived from them, or synthetic versions to enhance or restore immune function. It can be categorized into active, passive, and hybrid forms based on the approach to stimulate the immune response.
Immunotherapy has revolutionized cancer treatment by offering targeted therapies with fewer side effects than traditional treatments. It works either by stimulating the immune system to attack cancer cells or by providing it with components, such as immune system proteins. Checkpoint inhibitors, CAR-T cell therapy, and cancer vaccines are prime examples of this treatment.
Biomarkers play a pivotal role in predicting the response to immunotherapy. Common biomarkers include PD-L1 expression and microsatellite instability. Understanding these biomarkers can guide physicians in choosing the appropriate immunotherapy treatment for individual patients.
While immunotherapy has revolutionized cancer treatment, it is not devoid of side effects. These can range from mild fatigue to severe immune-related adverse events. Early recognition and management of these side effects are crucial to ensure patient safety and treatment efficacy.
Immunotherapy marks a new era in the fight against cancer and other diseases. As the field continues to evolve, physicians must stay abreast of the latest developments to provide the best possible care to their patients. Understanding the fundamentals of immunotherapy, its applications, and potential side effects is key to harnessing its full potential in clinical practice.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation